Key facts
- This page summarizes John P. Brancaccio's Form 4 filing for Cardiff Oncology, Inc. (CRDF).
- 9 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2022, 19:48.
John P. Brancaccio - 09 Jun 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)
- Reporting relationship
- Former Director
- Issuer ticker
- CRDF
- Reported as of
- 09 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2022, 19:48:59 UTC
- Prior SEC filing
- 16 May 2022
- Next SEC filing
- 28 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Brancaccio
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John P. Brancaccio filed Form 4 for Cardiff Oncology, Inc. (CRDF) on 09 Jun 2022.
Change
- Previous filing in this sequence was filed on 16 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +26,800
- Change %
- +27%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,800
- Exercise price
- $2.50
- Footnotes
- F1
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +22,000
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,000
- Exercise price
- $7.98
- Footnotes
- F2
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +28,858
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,858
- Exercise price
- $2.60
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +44,734
- Change %
- +56%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,734
- Exercise price
- $2.48
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +755
- Change %
- +0.61%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 755
- Exercise price
- $21.60
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +530
- Change %
- +0.42%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 530
- Exercise price
- $51.84
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +223
- Change %
- +0.18%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 223
- Exercise price
- $372.96
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +223
- Change %
- +0.18%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 223
- Exercise price
- $516.96
- Footnotes
- F3
CRDF
transaction
Derivative
Stock Options
Other
- Transaction value
- $0
- Shares
- +195
- Change %
- +0.16%
- Price
- $0.000000
- Shares after
- 125,317
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 195
- Exercise price
- $316.08
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 26,800 stock options to June 9, 2022 from March 9, 2023. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024.
Footnote F2
In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 22,000 stock options to June 9, 2022 from June 10, 2022. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024.
Footnote F3
Expiration date of the stock options was extended to June 9, 2024.